ASX - By Stock
|
PAR |
Re:
Ann: Change in substantial holding
|
|
Robbie1
|
22 |
8.8K |
0 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
22
|
8.8K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
4 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Robbie1
|
4.2K |
3.8M |
19 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
19
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
14 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
14
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Robbie1
|
115 |
58K |
0 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
115
|
58K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Robbie1
|
4.2K |
3.8M |
13 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Robbie1
|
4.2K |
3.8M |
6 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
Robbie1
|
255 |
158K |
69 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
255
|
158K
|
69
|
|
ASX - By Stock
|
RPM |
Re:
Ann: FY 22 Results Investor Presentation
|
|
Robbie1
|
39 |
12K |
0 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
39
|
12K
|
0
|
|
ASX - By Stock
|
RPM |
Re:
Ann: FY 22 Results Investor Presentation
|
|
Robbie1
|
39 |
12K |
0 |
09/09/22 |
09/09/22 |
ASX - By Stock
|
39
|
12K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR stock price - what should today's value be?
|
|
Robbie1
|
36 |
17K |
11 |
04/09/22 |
04/09/22 |
ASX - By Stock
|
36
|
17K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Presentation - $66m Capital Raise
|
|
Robbie1
|
87 |
35K |
4 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
87
|
35K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm on the television .
|
|
Robbie1
|
63 |
26K |
4 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
63
|
26K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Paradigm on the television .
|
|
Robbie1
|
63 |
26K |
27 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
63
|
26K
|
27
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm provides MPS Clinical Program update
|
|
Robbie1
|
9 |
6.3K |
16 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
9
|
6.3K
|
16
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Appendix 4C and Investor Conference Call Details
|
|
Robbie1
|
6 |
1.2K |
1 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
6
|
1.2K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Robbie1
|
4.2K |
3.8M |
1 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
4.2K
|
3.8M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
16 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
16
|
|
ASX - By Stock
|
PAR |
Re:
PARate Day Share Price 2022
|
|
Robbie1
|
116 |
51K |
0 |
07/05/22 |
07/05/22 |
ASX - By Stock
|
116
|
51K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Update and Appendix 4C - quarterly
|
|
Robbie1
|
36 |
13K |
26 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
36
|
13K
|
26
|
|
ASX - By Stock
|
PAR |
Re:
Something afoot at PAR?
|
|
Robbie1
|
54 |
25K |
5 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
54
|
25K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Something afoot at PAR?
|
|
Robbie1
|
54 |
25K |
2 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
54
|
25K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
29 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
29
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change in substantial holding
|
|
Robbie1
|
14 |
6.3K |
10 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
14
|
6.3K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Why are people selling?
|
|
Robbie1
|
41 |
15K |
10 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
41
|
15K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
10 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
4.1K
|
1.9M
|
10
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Robbie1
|
339 |
138K |
16 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
339
|
138K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Robbie1
|
339 |
138K |
1 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
339
|
138K
|
1
|
|
ASX - By Stock
|
PAR |
2022 PAR AGM
|
|
Robbie1
|
12 |
5.0K |
39 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
12
|
5.0K
|
39
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Robbie1
|
339 |
138K |
32 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
339
|
138K
|
32
|
|
ASX - By Stock
|
EML |
Re:
Ann: Class Action Proceedings
|
|
Robbie1
|
4 |
2.4K |
0 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
4
|
2.4K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR General discussion
|
|
Robbie1
|
339 |
138K |
17 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
339
|
138K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
4 |
11/12/21 |
11/12/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR Investor Meeting - Questions from HC
|
|
Robbie1
|
122 |
39K |
19 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
122
|
39K
|
19
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
5 |
27/11/21 |
27/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
12 |
27/11/21 |
27/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
12
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
4 |
20/11/21 |
20/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
2 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
11 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
11
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Trading Halt
|
|
Robbie1
|
6 |
3.1K |
1 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
6
|
3.1K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
2 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
44 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
44
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
19 |
06/11/21 |
06/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
19
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
0 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
0 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Robbie1
|
4.1K |
1.9M |
6 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
4.1K
|
1.9M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
Robbie1
|
191 |
75K |
8 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
75K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
|
|
Robbie1
|
191 |
75K |
12 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
191
|
75K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Robbie1
|
150 |
74K |
12 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
150
|
74K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Robbie1
|
150 |
74K |
4 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
150
|
74K
|
4
|
|